Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,236 | Dovepress* | 8,738+ | 809 | 9,547 | |
PubMed Central* | 1,498 | 208 | 1,706 | ||
Totals | 10,236 | 1,017 | 11,253 | ||
*Since 31 October 2017 |
View citations on PubMed Central and Google Scholar